SCHEMBL8847871

SCHEMBL8847871

CCCCC(C([NH])=O)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.40
MAPK1 P28482 1/20 0.40
CA1 P00915 6/20 0.39
SLC15A1 P46059 1/20 0.37
FDPS P14324 1/20 0.37
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
ACE2 Q9BYF1 1/20 0.35
CTSK P43235 1/20 0.35
GPR84 Q9NQS5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8847495 0.86 CHRM1 (0.39) CA2CA1FDPS
SCHEMBL20489978 0.79 CA2 (0.41) CA2MAPK1CA1SLC15A1FDPS
SCHEMBL406135 0.79 CA2 (0.52) CA2MAPK1CA1ACE2GPR84
SCHEMBL3127227 0.79 CA2 (0.41) CA2MAPK1CA1SLC15A1FDPS
SCHEMBL7316786 0.77 CA2 (0.54) CA2MAPK1CA1SLC15A1FDPS
SCHEMBL7325930 0.77 CA2 (0.54) CA2MAPK1CA1SLC15A1FDPS
SCHEMBL9831486 0.77 CA2 (0.54) CA2MAPK1CA1SLC15A1FDPS
SCHEMBL277109 0.76
SCHEMBL275962 0.75
SCHEMBL11458224 0.74 CA2 (0.38) CA2MAPK1CA1SLC15A1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5614519-A (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists KARL THOMAE GMBH (DE) 1997-03-25 US disclosed
US-5602127-A ADMINISTERING TO TREAT HYPERTENSION KARL THOMAE GMBH (DE) 1997-02-11 US disclosed
US-5594003-A HYPOTENSIVE AGENTS DR. KARL THOMAE GMBH (DE) 1997-01-14 US disclosed
US-5591762-A HYPOTENSIVE AGENTS DR. KARL THOMAE GMBH (DE) 1997-01-07 US disclosed